ResMed Inc. (ResMed) develops, manufactures and distributes of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders. Sleep-disordered breathing (SDB), includes obstructive sleep apnea (OSA), and other respiratory disorders that occur during sleep. It has developed a number of products for SDB and other respiratory disorders including airflow generators, diagnostic products, mask systems, headgear and other accessories. 

Company Growth (employees)
San Diego, US
Size (employees)
5,250 (est)
ResMed was founded in 1989 and is headquartered in San Diego, US

ResMed Office Locations

ResMed has offices in San Diego, Kontich, Espoo, Moissy-Cramayel and in 24 other locations
San Diego, US (HQ)
9001 Spectrum Center Blvd
Rochester, US
1200 Brooks Ave
Singapore, SG
8 Loyang Cres
Hong Kong, HK
132 Nathan Rd
Guangzhou Shi, CN
Jian She Liu Ma Lu
Shanghai, CN
Wagas ( Shan Xi Bei Lu )
Show all (28)

ResMed Data and Metrics

ResMed Financial Metrics

ResMed's revenue was reported to be $514.2 m in Q3, 2017

Revenue (Q3, 2017)

514.2 m

Gross profit (Q3, 2017)

299.7 m

Gross profit margin (Q3, 2017), %


Net income (Q3, 2017)

87.8 m

EBIT (Q3, 2017)

107.4 m

Market capitalization (22-Sep-2017)

11 b

Cash (31-Mar-2017)

827.3 m
ResMed's current market capitalization is $11 b.
USDFY, 2014FY, 2015FY, 2016


1.6 b1.7 b1.8 b

Revenue growth, %


Cost of goods sold

667.5 m772.2 m

Gross profit

1 b1.1 b
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017


380.4 m423 m422.5 m411.6 m454.5 m453.9 m465.5 m530.4 m514.2 m

Cost of goods sold

143.1 m159.7 m171.1 m173 m188 m194 m196.3 m221.3 m214.5 m

Gross profit

237.3 m263.2 m251.4 m238.6 m266.5 m259.9 m269.2 m309.1 m299.7 m

Gross profit Margin, %

USDFY, 2014FY, 2015FY, 2016


905.7 m717.2 m731.4 m


165.4 m246.9 m224.5 m

Current Assets

1.6 b1.4 b1.4 b


434.3 m387.8 m384.3 m
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017


881.7 m880.7 m866.3 m822.1 m658.8 m718.5 m781.7 m788.1 m827.3 m


197.2 m218.1 m225.2 m258.6 m237.5 m232.9 m253.8 m253.1 m259.9 m

Current Assets

1.5 b1.6 b1.6 b1.5 b1.4 b1.4 b1.5 b1.5 b1.6 b


419.8 m408.2 m384.2 m369 m375.2 m386.8 m390.8 m375.9 m387.4 m
USDFY, 2014FY, 2015FY, 2016

Net Income

345.3 m352.9 m352.4 m

Depreciation and Amortization

73.5 m73.1 m86.8 m

Accounts Receivable

(35 m)(28 m)(27.3 m)

Cash From Operating Activities

391.3 m383.2 m547.9 m
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Net Income

83.3 m91.2 m91 m80.4 m90.5 m88.5 m76.1 m76.7 m87.8 m

Depreciation and Amortization

18.4 m

Accounts Receivable

30.5 m


197.2 m218.1 m225.2 m237.5 m232.9 m253.8 m253.1 m259.9 m
USDY, 2017


97.9 k

Financial Leverage

1.8 x
Show all financial metrics

ResMed Market Value History

ResMed Median Salaries

Source: 31 public H-1B filings from ResMed

Traffic Overview of ResMed

ResMed Online and Social Media Presence

ResMed News and Updates

Ventilator Market Size & Share set for accelerated growth by 2022

The market is driven by the factors such as increasing geriatric population and rising level of air pollution globally. Posted via Industry Today. Follow us on Twitter @IndustryToday

ResMed Company Life and Culture

You may also be interested in